SCHEMBL6370665

SCHEMBL6370665

C=CCn1c(/C=C/CO)cc2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.38
LMNA P02545 1/20 0.38
KDM4E B2RXH2 3/20 0.36
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP2C9 P11712 1/20 0.36
PTK2B Q14289 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
HRH1 P35367 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6370673 1.00 PARP1 (0.38) PARP1LMNAKDM4EPOLBNPSR1
SCHEMBL6364991 0.79 LMNA (0.40) PARP1LMNAKDM4EPOLBNPSR1
SCHEMBL6364996 0.79 LMNA (0.40) PARP1LMNAKDM4EPOLBNPSR1
SCHEMBL6368592 0.79 KDM4E (0.39) LMNAKDM4ECYP1A2CYP2C19SMN1; SMN2
SCHEMBL6368595 0.79 KDM4E (0.39) LMNAKDM4ECYP1A2CYP2C19SMN1; SMN2
SCHEMBL14387230 0.78 LMNA (0.41) PARP1LMNAKDM4EPOLBNPSR1
SCHEMBL6364572 0.75 GRIN2D (0.49) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL6364574 0.75 GRIN2D (0.49) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL28237309 0.75 LMNA (0.41) PARP1LMNAKDM4EPOLBNPSR1
SCHEMBL6369104 0.75 MAPK1 (0.45) LMNAKDM4EPOLBNPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070591-A1 Indole derivative KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070591-A1 Indole derivative TPH1, IDO1, RBX1 PARP1 3489/4885LMNA 4014/4885KDM4E 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.